YadA inhibitors belong to a unique class of chemical compounds designed to target the YadA protein, which is primarily found in certain pathogenic bacteria. YadA, short for "Yersinia adhesin A," is a surface protein expressed by bacteria belonging to the Yersinia genus, such as Yersinia enterocolitica and Yersinia pseudotuberculosis. This protein plays a crucial role in the initial stages of host-pathogen interactions, as it functions as an adhesin and invasin, allowing the bacterium to adhere to host cells and facilitate its entry into the host organism. YadA is a significant virulence factor and contributes to the pathogenicity of these bacteria, making it an attractive target for the development of inhibitors.
YadA inhibitors are designed to disrupt the interaction between the YadA protein and host cells. These chemical compounds are typically small molecules that can bind to specific regions of the YadA protein, thereby blocking its adhesion to host cell receptors. By inhibiting this crucial step in the infection process, YadA inhibitors impedes the ability of Yersinia bacteria to establish infections and cause diseases in the host. The development of YadA inhibitors represents a promising avenue in the field of anti-infective research, as it offers a strategy to combat Yersinia infections at their root, by targeting a fundamental aspect of the pathogen's virulence. This class of compounds is the subject of ongoing research aimed at better understanding their mechanism of action and optimizing their effectiveness in combating Yersinia-associated diseases.
Items 11 to 20 of 23 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
AKT inhibitor interfering with the PI3K/Akt pathway, thus impeding YadA expression and function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Natural product that modulates multiple signaling pathways, potential anti-cancer agent. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
AKT inhibitor targeting the PI3K/Akt pathway, leading to suppression of downstream signaling pathways that regulate YadA. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
ACE inhibitor, used to lower blood pressure in hypertension. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
Dual PI3K/mTOR inhibitor affecting the PI3K/Akt/mTOR pathway, causing inhibition of YadA expression and function. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
PI3K inhibitor impacting the PI3K/Akt pathway, leading to suppression of downstream signaling cascades regulating YadA. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Acetylcholinesterase inhibitor, improves cognitive function in Alzheimer′s disease. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, disrupting cell division in cancer chemotherapy. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AKT inhibitor disrupting the PI3K/Akt pathway, ultimately suppressing YadA expression and function. | ||||||
Vemurafenib | 918504-65-1 | sc-364643 sc-364643A | 10 mg 50 mg | $117.00 $423.00 | 11 | |
Selective BRAF kinase inhibitor, used in melanoma with BRAF mutations. | ||||||